News

Ken Frazier on Merck’s COVID Response

Ken Frazier on Merck’s COVID Response

Kenneth C. Frazier of Merck was interviewed by Bloomberg Law about the company’s approach to tackling the pandemic and its efforts to develop a COVID-19 vaccine.

Mr. Frazier spoke on prioritization in the distribution of a vaccine—with healthcare workers and high-risk groups being at the top of the list—and the company's commitment to ensuring broad, affordable access when a vaccine does become available.

Read the full piece here.  

Featured Members